Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric Cancer — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Zolbetuximab Claudin18.2 Positive, HER2 Negative, Advanced Gastric Cancer — Stella

Recruiting

Back to Advanced Gastric Cancer trials

Trial locations(1 site)

South Korea

Severance Hospital, Seoul

Key details

Sponsor

Yonsei University

Enrollment target

~80 participants

Started

December 2024

Primary completion

December 2026

Age range

19 Years and older

Last updated January 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov